Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
Start Date
11/7/2025
Completion Date
10/1/2027
Summary
A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial
Detailed Description
To evaluate the safety and effectiveness of VisiPlate Aqueous Shunt to lower intraocular pressure (IOP) in subjects with open-angle glaucoma for whom medical and surgical treatments have failed.
Eligibility Criteria
Age Range: 45 years to No maximum
Interventions
VisiPlate Glaucoma Implant
Conditions
Locations
Arizona Advanced Eye Research
Glendale, Arizona 85306
United States
Sacramento Eye Consultants
Sacramento, California 95815
United States
ICON Eye Care
Grand Junction, Colorado 81501
United States
Mile High Eye Institute
Sheridan, Colorado 80226
United States
Cleveland Clinic- Cole Eye Institute
Cleveland, Ohio 44195
United States
Scheie Eye Institute
Philadelphia, Pennsylvania 19104
United States
Wills Eye Hospital
Philadelphia, Pennsylvania 19107
United States
Glaucoma Associates of Texas
Dallas, Texas 75231
United States
University of Texas Southwestern
Dallas, Texas 75390
United States
The Eye Centers of Racine & Kenosha
Kenosha, Wisconsin 53142
United States
Lynette Venter
Bloemfontein, 9301
South Africa
Pretoria Eye Institute
Pretoria, 0007
South Africa